|
From: Chris T. <chr...@eb...> - 2007-10-12 10:17:56
|
Hi all. My sincere apologies for missing the call yesterday -- like an idiot I messed up the time by an hour and was dutifully on the phone at 4pm uk time (instead of 3). Anyway some comments on the minutes, for what it is worth: > In addition, Rima Kaddurah-Daouk will send out a letter to the > Metabolomics Society members (which will be drafted by Oliver > Fiehn) that calls for community feedback based on the current MSI > documents. This period of feedback should extend to 6 months to > gather a certain amount of experience. It is crucial that this be promoted more widely than just the society (whether any extra responses are generated from that or not) if the guidelines are intended to apply to that wider community (think about the general science journals -- for example Nature Group would not have taken the 'word' of PSI/HUPO that we got things right and even after running their own consultation exercise they will not implement immediately -- not till there are good tools). So at the very least we need another letter to as many big journals as will take it promoting again the location of the documents and the feedback mechanism. Probably there should be prior agreement from each journal that takes such a letter that they will start to encourage voluntary compliance for a probationary period (no-one will enforce straight away); a sweetener Could be to have submitters who provide compliant data sets benefit from a form of 'fast tracking' to print. Crucially, we need clear mechanisms in place though (in the form of a formal _process_ document) if these standards are to thrive -- without a visibly-responsive channel for comment and a robust, explicit process for revision I don't think they'll do as well as they could (i.e. to succeed in journals outside the sphere of influence of senior MSI participants), as they will be perceived as a static entity generated by a subset of the community they apply to, with no way for the balance of that community to 'come on board'. Incdentally, NBT now expect that the MIAPE authors who are experimentalists will provide MIAPE compliant material :) I'm not sure they all knew that when they signed on but it is now the case -- I think that reinforces your commendable idea that MSI participants should lead by example, i.e. from the front. > /__/ > * /_(b) efforts to continue group activities towards ‘best practice’ > documents_/ > Currently, MSI groups are mostly dormant. Writing initial MSI > papers helped fostering group activities but groups have not been > active since. The idea was revitalized to unify the ‘biological > context’ documents into a single ‘umbrella’ document that would > have further details for the different research areas; however, TC > participants did not actively agree on that. A reasonable course of action here is to pursue that goal through MIBBI, thereby involving other relevant groups such as the genomic sequencing people and others concerned with the description of the origin of a sample. This is also an issue further along the workflow as it were -- chemical analysis, PSI and a couple of other groups need to chat for one; then there's the likely leading role in the stats activity within MIBBI to be taken by the data analysis group of MSI. Again we desperately need clear documented processes so that come the time that integrated reporting standards are available from MIBBI, the different contributing communities can credibly sign off on them. > A disagreement was stated on the usefulness of working towards > ‘best practice’ documents, especially for the ‘data processing’ > working group. One argument raised was that any official MSI ‘best > practice’ document would be counterproductive because such an > official stamp would be easily violating the idea of a > continuation of improving practices and methods. Instead, a group > of individuals might publish their view of ‘current best practice’ > in order to lead by example which could be improved by other > authors using the regular way of scientific discussion. This is a minefield and I would counsel extreme caution. I know everyone knows that it's a potentially controversial area, but my specific point is that to link the relatively uncontroversial (by comparison) activity of guidelines/formats/CV development to arguing about best practice threatens to bog down our current products in the unending scrap about whose favourite method is best (whatever the objective merits of each). These things are best kept completely separate. If there is a real will to do it then perhaps the approach taken by HUPO, of instituting an entirely separate body to do it, would be best. > Nevertheless, the point was raised that for ‘data processing’ it > would be really hard to distinguish between ‘minimal standards’ > and ‘best practice’ and that it would be MSI-compliant to report a > wrong way to do a certain piece of research (the same would of > course be true for all MSI-areas). So, in a way, right now > MSI-compliant would give papers or projects a touch of validation, > even if the study design or the way of data acquisition and > processing would be very bad. Such quality judgements are (even where most think it clear cut) a nightmare for all sorts of reasons and even for the DA group (as we discussed on Boston) this is not a good idea. It is _always_ possible to provide guidance on how to report _without_ straying into value judgements. Really such judgements are best made by referees, guided by journal policy (reference Molecular and Cellular Proteomics' approach to this wrt mass spectrometry -- they are very clear about their view of certain methods). If the wider Society wants to have an input to that and try to help build consensus amongst journals (itself an almost impossible goal anyway tbh) then fine, but I implore you, keep it separate from the other standards stuff. We don't need to argue about the pipes _and_ what should flow through them at the same time. > This discussion was consolidated in the general agreement that > ‘lead-by-example’ papers will also serve as best practice > documents. One of such instances is a current submission to the > journal Metabolomics on use and misuse of PLS in statistics. This is a good approach, because the leverage comes through the journal and the community, rather than an 'authority'; really though this is just a recasting of how things happen anyway no? > * /_(c) efforts to draft instances of units and data exchange > formats originating from the ‘minimal’ standards_// > /In practical terms, currently there are a variety of efforts > underway to accumulate data and distribute these via websites. > However, none of the current efforts really embrace the need of > data exchange formats in order to standardize and compile > different data sets or data sets of different origins. Some > cyberinfrastructure projects (e.g. NSF funded in plant science) > will be carried out that might yield standardized repositories, > e.g. for biological context data. It is unclear, if other fields > of research (e.g. clinical, biomedical) have similar efforts, but > it is clear that currently, there are no efforts for (U.S.) > national repositories for metabolomics data although in Europe, > there are consortia (e.g. Metafor) that might be working into that > direction. So, for now this topic is an unsolved problem that > would require active research and funding to go forward. Well, there is some stuff coming; funding is always tricky but we're nearly there at EBI for one (probably two years maximum to a working three-omics system). A different approach is to build something that is just 'FuGE-friendly' (FuGE was in NBT this month btw) like CPAS -- that way the domain specificity is sacrificed but nothing is lost per se. In the interim such an approach can fairly straightforwardly provide the repository needed, while we wait for more sophisticated resources; that said I'm not aware of many doing that at the moment apart from the Fred Hutch (CPAS) and a couple of universities in the UK (not for general use though). There is a strong argument that if the job is done unimpeachably with the MI documents and they achieve decent market penetration then you create a market for databases and tools from both the public and private sectors and thus (with a little encouragement) tools and DBs will 'appear'. Honest. > * /_other points > _/Before an email can be sent to the Metabolomics Soc members, it > is important to ensure that the *msi-sourceforge* pages are up to > date. Nigel will contact Susanna on that behalf to find out. The > pages might need to be revisited with respect to easiness of > communication and use – if we want to obtain feedback from members > (or other researchers), there must be low-entry ways to do so. A > wiki attached to the sourceforge pages was discussed or branching > out to the Metabolomics Society pages. > With respect to contacts to other efforts, especially the *MIBBI* > efforts led by Chris Taylor, Nigel will serve as contact point (in > addition to Susanna’s continuing efforts). It is anticipated that > there potentially might be significant synergies that could be > gathered from such unifying biology-focused reporting efforts. > Susanna has acquired funding for workshop(s) that will foster > efforts in this direction. // Great to see that -- thanks. I'll of course have my brain engaged though and will be able to make future calls myself to represent MIBBI. I do think there's more to do for the MI groups though than ensure that the email address(es) work okay and such -- we need stated (in documents) mechanisms and structures -- we have to be a grown up body now in the manner of any of the large standards bodies. Confidence will be inspired in others by our having a visible process that works and that we cannot lightly alter. If there is even the chance that we could arbitrarily alter the 'release' version of these things, confidence (especially in commercial settings) will evaporate quicker than liquid helium at RTP. Sorry for the length... Cheers, Chris. ~~~~~~~~~~~~~~~~~~~~~~~~ chr...@eb... http://mibbi.sf.net/ ~~~~~~~~~~~~~~~~~~~~~~~~ |